6,155 Shares in SPDR S&P Biotech ETF $XBI Purchased by Larry Mathis Financial Planning LLC

Larry Mathis Financial Planning LLC bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 6,155 shares of the exchange traded fund’s stock, valued at approximately $786,000.

Other institutional investors also recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its stake in SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares in the last quarter. Marshall Wace LLP increased its holdings in SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares during the period. The Manufacturers Life Insurance Company bought a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at $260,000. Ameriprise Financial Inc. raised its position in SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Finally, EP Wealth Advisors LLC raised its position in SPDR S&P Biotech ETF by 3.7% during the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after purchasing an additional 193 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 2.5%

Shares of XBI stock opened at $155.38 on Friday. SPDR S&P Biotech ETF has a twelve month low of $82.04 and a twelve month high of $155.93. The stock has a fifty day simple moving average of $135.24 and a two-hundred day simple moving average of $128.70. The stock has a market capitalization of $9.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.